Skip to content
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT

Meet our team

Everyone has been impacted by mental health and our expert team is no exception. Our people bring experience and expertise across multiple fields to deliver a real solution to the mental health crisis.

Scientific Advisory Board
Scientific Advisory Board

asdvvasdv

Hear more from the team

Interviews

mike thompson MBE
  • July 22, 2022

Introduction to Mike Thompson MBE

Interviews

fungi mycelium mycology
  • June 29, 2022

Fungi, Mycelium and Mycology with Dr. Jonathan Curry

Interviews

Youtube Schema Psilocybin Mental Health
  • June 8, 2022

How might psilocybin change the way we treat mental health and cancer-related distress?

Interviews

sara tai principal investigator
  • May 26, 2022

Introducing Dr. Sara Tai

Interviews

psilocybin possession health canada
  • May 16, 2022

Albert Labs approved by Health Canada for psilocybin possession, production and delivery license

Interviews

toxicology experts CESPU
  • May 12, 2022

Albert Labs announces partnership with drug safety & toxicology experts at the University of CESPU

Interviews

natural drug development, organic chemistry, scientific advisor from Simon Fraser University
  • April 28, 2022

Albert Labs adds natural drug development expert Prof. Rob Britton to its scientific advisory team

Interviews

toxicology, psychoactive and psilocybin scientific advisor
  • April 28, 2022

Albert Labs adds toxicology expert Dr. Ricardo Dinis-Oliveira to its scientific advisory team

Previous
Next

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2022 Albert Labs. All Rights Reserved

Hear more from our team

Our people bring experience and expertise across multiple fields to deliver a scalable solution to the mental health crisis.

  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact investing@albertlabs.com

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Announces Private Placement

Read more
Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Announces Private Placement

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.